Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2022 年第 1 季持倉
持倉截至 2022/3/31，2022/5/13 申報。只含多頭部位，變化是跟 2021 年第 4 季比股數。
- 持股檔數
- 48
- 較 2021 年第 4 季 +2
- 總值
- $2.52 億
- 較 2021 年第 4 季 +$1,780 萬 (+7.6%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| NARIInari Medical, Inc. | Stock | 220,000 | $1,994 萬 | 7.9% | +95,000+76.0% | 加碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 465,654 | $1,870 萬 | 7.4% | +66,352+16.6% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 924,147 | $1,486 萬 | 5.9% | +364,147+65.0% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 120,000 | $1,408 萬 | 5.6% | +120,000 | 新進 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 247,000 | $1,394 萬 | 5.5% | −51,545−17.3% | 減碼 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 845,155 | $1,383 萬 | 5.5% | +290,000+52.2% | 加碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 174,500 | $1,176 萬 | 4.7% | +97,000+125.2% | 加碼 | 歷史 |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $1,150 萬 | 4.6% | – | – | – |
| AZNAstraZeneca PLC | SPONSORED ADR | 160,000 | $1,061 萬 | 4.2% | +160,000 | 新進 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 207,500 | $957.4 萬 | 3.8% | +90,000+76.6% | 加碼 | 歷史 |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $775.3 萬 | 3.1% | – | 新進 | – |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 75,000 | $735.9 萬 | 2.9% | +10,000+15.4% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 300,000 | $710.4 萬 | 2.8% | +58,881+24.4% | 加碼 | 歷史 |
| ARYEARYA Sciences Acquisition Corp V | CLASS A ORD SHS | 702,500 | $682.8 萬 | 2.7% | 00.0% | 不變 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 468,905 | $667.7 萬 | 2.6% | +197,127+72.5% | 加碼 | 歷史 |
| LNTHLantheus Holdings, Inc. | Stock | 115,000 | $636.1 萬 | 2.5% | +115,000 | 新進 | 歷史 |
| NSTGNS Wind Down Co., Inc. | COM | 171,592 | $596.3 萬 | 2.4% | +171,592 | 新進 | 歷史 |
| VINCVincerx Pharma, Inc. | COM NEW | 1,374,098 | $549.6 萬 | 2.2% | +238,733+21.0% | 加碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 300,000 | $475.8 萬 | 1.9% | +135,000+81.8% | 加碼 | 歷史 |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $468.0 萬 | 1.9% | – | 新進 | – |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $438.0 萬 | 1.7% | – | – | – |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 125,000 | $425.8 萬 | 1.7% | +25,000+25.0% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 600,000 | $412.8 萬 | 1.6% | +100,000+20.0% | 加碼 | – |
| CBAYCymaBay Therapeutics, Inc. | COM | 1,272,244 | $395.7 萬 | 1.6% | +150,000+13.4% | 加碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 30,000 | $315.6 萬 | 1.3% | +30,000 | 新進 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 300,000 | $297.3 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| Medicus Sciences AcquisitionG5960S108 | CL A SHS | 300,000 | $293.4 萬 | 1.2% | 00.0% | 不變 | – |
| TVTXTravere Therapeutics, Inc. | COM | 100,000 | $257.7 萬 | 1.0% | +50,000+100.0% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 70,000 | $245.1 萬 | 1.0% | −155,000−68.9% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 80,000 | $244.6 萬 | 1.0% | −70,500−46.8% | 減碼 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 559,019 | $242.6 萬 | 1.0% | −490,702−46.7% | 減碼 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 70,000 | $242.5 萬 | 1.0% | +70,000 | 新進 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 100,000 | $172.4 萬 | 0.7% | −300,000−75.0% | 減碼 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 777,610 | $168.7 萬 | 0.7% | +777,610 | 新進 | 歷史 |
| Bio Green Med Solution, Inc.23254L603 | COM | 400,000 | $122.0 萬 | 0.5% | 00.0% | 不變 | – |
| LIANYLianBio | SPONSORED ADS | 325,000 | $120.6 萬 | 0.5% | +252,594+348.9% | 加碼 | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 221,382 | $118.4 萬 | 0.5% | +71,382+47.6% | 加碼 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 7,500 | $95.1 萬 | 0.4% | +7,500 | 新進 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 50,000 | $92.5 萬 | 0.4% | +50,000 | 新進 | 歷史 |
| RCORRenovacor, Inc. | COM | 199,490 | $84.6 萬 | 0.3% | +74,490+59.6% | 加碼 | 歷史 |
| CRISCuris Inc | COM NEW | 350,000 | $83.3 萬 | 0.3% | −300,000−46.2% | 減碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 65,282 | $58.6 萬 | 0.2% | −353,862−84.4% | 減碼 | 歷史 |
| CALACalithera Biosciences, Inc. | COM | 1,000,000 | $40.4 萬 | 0.2% | +1,000,000 | 新進 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $32.8 萬 | 0.1% | −2,796−1.5% | 減碼 | – |
| HYPRHyperfine, Inc. | COM CL A | 76,162 | $27.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 1,988 | $12.7 萬 | 0.1% | +1,988 | 新進 | 歷史 |
| Renovacor, Inc.75989E114 | *W EXP 99/99/999 | 75,000 | $2.60 萬 | <0.1% | 00.0% | 不變 | – |
| Medicus Sciences AcquisitionG5960S124 | *W EXP 02/12/202 | 33,333 | $1.40 萬 | <0.1% | 00.0% | 不變 | – |
選擇權（11 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | $3.39 億 | – |
| SWTXSpringWorks Therapeutics, Inc. | COM | $903.0 萬 | – |
| PMVPPMV Pharmaceuticals, Inc. | COM | – | $660.8 萬 |
| PTGXProtagonist Therapeutics, Inc | COM | $511.3 萬 | – |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | – | $345.2 萬 |
| RLAYRelay Therapeutics, Inc. | COM | – | $224.5 萬 |
| LNTHLantheus Holdings, Inc. | Stock | $221.2 萬 | – |
| AUPHAurinia Pharmaceuticals Inc. | COM | – | $216.7 萬 |
| BEAMBeam Therapeutics Inc. | COM | – | $171.9 萬 |
| ATHXAthersys, Inc | COM | $85.8 萬 | – |
| CELUCelularity Inc | COM CL A | $69.7 萬 | – |
2021 年第 4 季之後清倉（11 檔）
2021 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 4 季股數 | 2021 年第 4 季市值 | 2021 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ARNAArena Pharmaceuticals Inc | COM NEW | 100,000 | $929.4 萬 | 4.0% | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 494,046 | $824.1 萬 | 3.5% | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 145,552 | $663.4 萬 | 2.8% | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 400,000 | $397.2 萬 | 1.7% | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 175,000 | $383.1 萬 | 1.6% | 歷史 |
| Environmental Impact Acqu Co29408N106 | COM CL A | 300,000 | $297.6 萬 | 1.3% | – |
| MRTXMirati Therapeutics, Inc. | COM | 20,000 | $293.4 萬 | 1.3% | 歷史 |
| PRCTPROCEPT BioRobotics Corp | COM | 100,000 | $250.1 萬 | 1.1% | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 10,000 | $118.2 萬 | 0.5% | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 100,759 | $40.3 萬 | 0.2% | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 20,000 | $38.2 萬 | 0.2% | 歷史 |